Page last updated: 2024-10-28

hexamethylene bisacetamide and Carcinoma, Embryonal

hexamethylene bisacetamide has been researched along with Carcinoma, Embryonal in 7 studies

N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208

Carcinoma, Embryonal: A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, p1595)

Research Excerpts

ExcerptRelevanceReference
"Upon HMBA treatment, the embryonal carcinoma cell line NTERA-2 clone D1 (NT2/D1) accumulates in G1 and undergoes terminal differentiation."1.30Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation. ( Baldassarre, G; Barone, MV; Belletti, B; Boccia, A; Bruni, P; Fusco, A; Pepe, S; Romano, A; Sandomenico, C; Spiezia, S; Vento, MT; Viglietto, G, 1999)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (85.71)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayman, MW1
Christie, VB1
Keating, TS1
Przyborski, SA1
Andrews, PW2
Damjanov, I1
Berends, J1
Kumpf, S1
Zappavigna, V1
Mavilio, F1
Sampath, K1
Nakamura, T1
Okuyama, S2
Okamoto, S2
Nakajima, T2
Sekiya, S2
Oda, K2
Moasser, MM1
Khoo, KS1
Maerz, WJ1
Zelenetz, A1
Dmitrovsky, E1
Wakeman, JA1
Walsh, J1
Suzuki, M1
Shirasuna, K1
Hachiya, T1
Nojima, H1
Baldassarre, G1
Barone, MV1
Belletti, B1
Sandomenico, C1
Bruni, P1
Spiezia, S1
Boccia, A1
Vento, MT1
Romano, A1
Pepe, S1
Fusco, A1
Viglietto, G1

Other Studies

7 other studies available for hexamethylene bisacetamide and Carcinoma, Embryonal

ArticleYear
Following the differentiation of human pluripotent stem cells by proteomic identification of biomarkers.
    Stem cells and development, 2006, Volume: 15, Issue:2

    Topics: Acetamides; Antigens, Surface; Antigens, Tumor-Associated, Carbohydrate; Biomarkers; Carcinoma, Embr

2006
Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7).
    Laboratory investigation; a journal of technical methods and pathology, 1994, Volume: 71, Issue:2

    Topics: Acetamides; Antineoplastic Agents; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Carcin

1994
Down-regulation of the cyclin A promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site.
    Experimental cell research, 1995, Volume: 216, Issue:2

    Topics: Acetamides; Activating Transcription Factor 2; Activating Transcription Factors; Base Sequence; Bloo

1995
Derivation and characterization of retinoid-resistant human embryonal carcinoma cells.
    Differentiation; research in biological diversity, 1996, Volume: 60, Issue:4

    Topics: Acetamides; Animals; Antineoplastic Agents; Base Sequence; Carcinoma, Embryonal; Cell Differentiatio

1996
Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells.
    Oncogene, 1998, Jul-16, Volume: 17, Issue:2

    Topics: Acetamides; Base Sequence; Carcinoma, Embryonal; Cell Differentiation; Drosophila Proteins; Frizzled

1998
A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer.
    Oncogene, 1998, Aug-20, Volume: 17, Issue:7

    Topics: Acetamides; Amino Acid Sequence; Base Sequence; Carcinoma, Embryonal; Carrier Proteins; Cell Cycle P

1998
Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation.
    Oncogene, 1999, Nov-04, Volume: 18, Issue:46

    Topics: Acetamides; Antigens, Neoplasm; Antigens, Surface; Antigens, Tumor-Associated, Carbohydrate; Apoptos

1999